In response to a research group’s proposal for over-the-counter availability of rescue inhalers for asthma, another group advised that the benefits and risks of this recommendation need consideration, according to a letter in JAMA.
“With regard to over-the-counter albuterol, I am fearful this will lead to an increase in mortality,” John J. Oppenheimer, MD, clinical professor of medicine at UMDNJ University School of Medicine, a Healio Allergy/Asthma Peer Perspective Board Member and coauthor of the responding letter along with Kathleen R. May, MD, and Stanley J. Szefler, MD,